The report covers a forecast and an analysis of the transdermal drug delivery system market on a global and regional level. The study provides historical data from 2017 to 2018 and a forecast from 2019 to 2025 based on revenue (USD Million). The study includes the drivers and restraints of the transdermal drug delivery system market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the transdermal drug delivery system market on a global level.
In order to give the users of this report a comprehensive view of the transdermal drug delivery system market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new application launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.
The study provides a decisive view of the transdermal drug delivery system market is fragmented based on type, application, end-user, and region. The regional segment includes Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa.
Some key players in the transdermal drug delivery system market are GlaxoSmithKline, Novartis, Johnson & Johnson, Endo International, Purdue Pharma, Boehringer Ingelheim, Hisamitsu Pharmaceutical, Bristol-Myers Squibb, Mylan, and Bayer.
This report segments the global transdermal drug delivery system market into:
Global Transdermal Drug Delivery System Market: Type Analysis
Global Transdermal Drug Delivery System Market: End-User Analysis
Global Transdermal Drug Delivery System Market: Regional Analysis
In order to give the users of this report a comprehensive view of the transdermal drug delivery system market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new application launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.
The study provides a decisive view of the transdermal drug delivery system market is fragmented based on type, application, end-user, and region. The regional segment includes Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa.
Some key players in the transdermal drug delivery system market are GlaxoSmithKline, Novartis, Johnson & Johnson, Endo International, Purdue Pharma, Boehringer Ingelheim, Hisamitsu Pharmaceutical, Bristol-Myers Squibb, Mylan, and Bayer.
This report segments the global transdermal drug delivery system market into:
Global Transdermal Drug Delivery System Market: Type Analysis
- Transdermal Patches
- Drug-In-Adhesive Patches
- Matrix Patches
- Reservoir Membrane Patches
- Microneedle Patches
- Transdermal Semisolids
- Gels
- Ointments
- Sprays
- Pain Management
- Hormonal Applications
- Testosterone Replacement Therapy
- Transdermal Estrogen Therapy
- Central Nervous System Disorders
- Cardiovascular Diseases
- Other Applications
Global Transdermal Drug Delivery System Market: End-User Analysis
- Hospitals and Clinics
- Home Care Settings
Global Transdermal Drug Delivery System Market: Regional Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
Table of Contents
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Transdermal Drug Delivery System Market, 2017-2025 (USD Million)
- 2.2. Global Transdermal Drug Delivery System Market: Snapshot
- Chapter 3. Transdermal Drug Delivery System Market - Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Global Transdermal Drug Delivery System Market drivers: impact analysis
- 3.2.2. Increasing Prevalence of Chronic Diseases
- 3.2.3. Technological Advancements in Transdermal Drug Delivery Systems
- 3.3. Market Restraints
- 3.3.1. Global Transdermal Drug Delivery System Market restraints: impact analysis
- 3.3.2. Drug Failure and Recalls of Transdermal Drug Delivery Systems
- 3.3.3. Growing Use of Alternative Delivery Methods
- 3.4. Opportunities
- 3.4.1. Collaborations Between Pharmaceutical Companies and Drug Delivery Firms
- 3.4.2. Self-Administration and Home Care Drug Delivery Systems
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis, by type
- 3.6.2. Market attractiveness analysis, by application
- 3.6.3. Market attractiveness analysis, by End-User
- 3.6.4. Market attractiveness analysis, by region
- Chapter 4. Global Transdermal Drug Delivery System Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Transdermal Drug Delivery System Market: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New therapy launch
- 4.2.3. Agreements, partnerships, collaborations, and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Transdermal Drug Delivery System Market -Type Analysis
- 5.1. Global Transdermal Drug Delivery System Market: type overview
- 5.1.1. Global Transdermal Drug Delivery System Market Revenue Share, by type, 2018 and 2025
- 5.2. Transdermal Patches
- 5.2.1. Global Transdermal Drug Delivery System Market for Transdermal Patches, 2017-2025 (USD Million)
- 5.3. Transdermal Semisolids
- 5.3.1. Global Transdermal Drug Delivery System Market for Transdermal Semisolids, 2017-2025 (USD Million)
- 5.1. Global Transdermal Drug Delivery System Market: type overview
- Chapter 6. Global Transdermal Drug Delivery System Market - Application Analysis
- 6.1. Global Transdermal Drug Delivery System Market: application overview
- 6.1.1. Global Transdermal Drug Delivery System Market Revenue Share, by application, 2018 and 2025
- 6.2. Pain Management
- 6.2.1. Global Transdermal Drug Delivery System Market for Pain Management, 2017-2025 (USD Million)
- 6.3. Hormonal Applications
- 6.3.1. Global Transdermal Drug Delivery System Market for Hormonal Applications, 2017-2025 (USD Million)
- 6.4. Cardiovascular Diseases
- 6.4.1. Global Transdermal Drug Delivery System Market for Cardiovascular Diseases, 2017-2025 (USD Million)
- 6.5. Central Nervous System Disorders
- 6.5.1. Global Transdermal Drug Delivery System Market for Central Nervous System Disorders, 2017-2025 (USD Million)
- 6.6. Others
- 6.6.1. Global Transdermal Drug Delivery System Market for Others, 2017-2025 (USD Million)
- 6.1. Global Transdermal Drug Delivery System Market: application overview
- Chapter 7. Global Transdermal Drug Delivery System Market - End-User Analysis
- 7.1. Global Transdermal Drug Delivery System Market: End-User overview
- 7.1.1. Global Transdermal Drug Delivery System Market Revenue Share, by End-User, 2018 and 2025
- 7.2. Home Care
- 7.2.1. Global Transdermal Drug Delivery System Market for Home Care, 2017-2025 (USD Million)
- 7.3. Hospitals & Clinics
- 7.3.1. Global Transdermal Drug Delivery System Market for Hospitals & Clinics, 2017-2025 (USD Million)
- 7.1. Global Transdermal Drug Delivery System Market: End-User overview
- Chapter 8. Global Transdermal Drug Delivery System Market - Regional Analysis
- 8.1. Global Transdermal Drug Delivery System Market: regional overview
- 8.1.1. Global Transdermal Drug Delivery System Market Revenue Share, by region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.2.2. North America Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.2.3. North America Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.2.4. The U.S.
- 8.2.4.1. The U.S. Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.2.4.2. The U.S. Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.2.4.3. The U.S. Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.2.5. Canada
- 8.2.5.1. Canada Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.2.5.2. Canada Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.2.5.3. Canada Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.3.2. Europe Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.3.3. Europe Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.3.4. The U.K.
- 8.3.4.1. U.K. Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.3.4.2. U.K. Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.3.4.3. U.K. Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.3.5. Germany
- 8.3.5.1. Germany Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.3.5.2. Germany Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.3.5.3. Germany Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.3.6. France
- 8.3.6.1. France Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.3.6.2. France Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.3.6.3. France Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.3.7. Rest of Europe
- 8.3.7.1. Rest of Europe Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.3.7.2. Rest of Europe Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.3.7.3. Rest of Europe Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.4.2. Asia Pacific Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.4.3. Asia Pacific Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.4.4. China
- 8.4.4.1. China Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.4.4.2. China Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.4.4.3. China Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.4.5. Japan
- 8.4.5.1. Japan Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.4.5.2. Japan Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.4.5.3. Japan Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.4.6. India
- 8.4.6.1. India Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.4.6.2. India Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.4.6.3. India Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.4.7. Rest of Asia Pacific
- 8.4.7.1. Rest of Asia Pacific Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.4.7.2. Rest of Asia Pacific Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.4.7.3. Rest of Asia Pacific Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.5.2. Latin America Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.5.3. Latin America Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.5.4. Brazil
- 8.5.4.1. Brazil Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.5.4.2. Brazil Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.5.4.3. Brazil Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.5.5. Rest of Latin America
- 8.5.5.1. Rest of Latin America Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.5.5.2. Rest of Latin America Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.5.5.3. Rest of Latin America Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa Transdermal Drug Delivery System Market Revenue, by type, 2017-2025 (USD Million)
- 8.6.2. The Middle East and Africa Transdermal Drug Delivery System Market Revenue, by application, 2017-2025 (USD Million)
- 8.6.3. The Middle East and Africa Transdermal Drug Delivery System Market Revenue, by End-User, 2017-2025 (USD Million)
- 8.1. Global Transdermal Drug Delivery System Market: regional overview
- Chapter 9. Company Profile
- 9.1. Baxter International
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. GlaxoSmithKline
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. Novartis
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. Johnson & Johnson
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. Endo International
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. Purdue Pharma
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. Boehringer Ingelheim
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. Hisamitsu Pharmaceutical
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.9. Bristol-Myers Squibb Company
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product portfolio
- 9.9.4. Business strategy
- 9.9.5. Recent developments
- 9.10. Mylan
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product portfolio
- 9.10.4. Business strategy
- 9.10.5. Recent developments
- 9.11. Bayer
- 9.11.1. Overview
- 9.11.2. Financials
- 9.11.3. Product portfolio
- 9.11.4. Business strategy
- 9.11.5. Recent developments
- 9.1. Baxter International
